Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Almorexant for Treatment of Primary Insomnia

There are a number of endpoints that can be used to assess the efficacy of drugs for insomnia some of which are sleep-specific outcome measures while others are designed to assess treatment impact on patient well-being.



Go Top